MIRA INFORM REPORT

 

 

Report Date :

14.08.2014

 

IDENTIFICATION DETAILS

 

Name :

SRL LIMITED [w.e.f.06.07.2012]

 

 

Formerly Known As :

SUPER RELIGARE LABORATORIES LIMITED [w.e.f.28.08.2008]

 

SRL RANBAXY LIMITED

 

SPECIALTY RANBAXY PRIVATE LIMITED

 

 

Registered Office :

Plot No. D-3, A Wing, 2nd Floor, District Centre, Saket, New Delhi - 110017

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

07.07.1995

 

 

Com. Reg. No.:

55-070603

 

 

Capital Investment / Paid-up Capital :

Rs. 844.635 Millions

 

 

CIN No.:

[Company Identification No.]

U74899DL1995PLC070603

 

 

PAN No.:

[Permanent Account No.]

AAACS2809J

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged in the business of establishing, maintaining and managing clinical reference laboratories, to provide testing, diagnostics and prognostics monitoring/ screening tests on human beings and also provides laboratory support services for clinical research studies.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (66)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

 

Maximum Credit Limit :

USD 29000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having fine track record.

 

Financial position of the company seems to be sound.

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

The company can be considered normal for business dealings at usual trade terms and conditions.  

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Fund based – Cash Credit = A

Rating Explanation

Have adequate degree of safety and carry low credit risk.

Date

September 2013

 

 

Rating Agency Name

ICRA

Rating

Fund based – Short Term Loans = A1

Rating Explanation

Have very strong degree of safety and carry lowest credit risk.

Date

September 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE

 

[CONTACT NO.: 91-11-42295333]

 

 

LOCATIONS

 

Registered Office :

Plot No. D-3, A Wing, 2nd Floor, District Centre, Saket, New Delhi – 110017, India

Tel. No.:

91-11-42295333

Fax No.:

91-11-42295395

E-Mail :

ravi.batra@srl.in

ankush.agarwal@srl.in

connect@srl.in

Website :

https://www.srl.in

http://www.srlworld.com

 

 

Corporate Office :

GP-26, Maruti Industrial Estate, Udyog Vihar, Sector 18, Gurgaon – 122015, Haryana, India 

Tel. No.:

91-124-3001243/ 3001209

 

 

Delhi Office :

Vasant Vihar, 8 Palam Marg, New Delhi – 110057, India

Tel. No.:

91-11-42295333

 

 

DIRECTORS

 

AS ON 20.09.2013

 

Name :

Mr. Sanjeev Krishan Chaudhry

Designation :

Managing director

Address :

Garden Homes 21, Celebrity Homes, Palam Vihar, Gurgaon – 122017, Haryana, India

Date of Birth/Age :

19.03.1959

Qualification :

PhD (Business Administration, Masters in Economics)

Experience :

33 Years

Date of Appointment :

04.02.2011

PAN No.:

AACPC0321Q

DIN No.:

00015077

 

 

Name :

Mr. Shivinder Mohan Singh

Designation :

Director

Address :

House No. 1, South End Lane, New Delhi – 110011, India

Date of Birth/Age :

21.07.1975

Qualification :

Master's Degree in Business Admn From Duke Univ, USA

Date of Appointment :

07.05.2002

PAN No.:

AAKPS4318M

DIN No.:

00042910

 

 

Name :

Mr. Malvinder Mohan Singh

Designation :

Director

Address :

Vistas - 26, Maulsari Avenue, Westend, Green Farm, Rajokri, New Delhi – 110038, India

Date of Birth/Age :

27.11.1972

Qualification :

Master's Degree in Business Admn From Duke Univ, USA

Date of Appointment :

24.11.1999

PAN No.:

AABPS2552G

DIN No.:

00042981

 

 

Name :

Mr. Harpal Singh

Designation :

Director

Address :

B-10, Anand Niketan, New Delhi – 110021, India

Date of Birth/Age :

11.09.1949

Qualification :

Master's Degree in Public Affairs from California State Univ, Hayward, California USA

Date of Appointment :

07.05.2002

DIN No.:

00078224

 

 

Name :

Mr. Sunil Naraindas Godhwani

Designation :

Director

Address :

A-2, Inayat Farm, Asola, Fatehpur Beri, Po – Mehrauli, New Delhi – 110030, India

Date of Birth/Age :

10.12.1960

Qualification :

Master's Degree in Indl. Engg and Finance from Polytechnic Institute of New York

Date of Appointment :

12.06.2007

DIN No.:

00174831

 

 

Name :

Mr. Aditya Vij

Designation :

Director

Address :

3.27, Second Floor, Shanti Niketan, New Delhi – 110021, India

Date of Birth/Age :

24.10.1958

Qualification :

CA

Date of Appointment :

23.05.2012

DIN No.:

03200194

 

 

Name :

Mr. Achal Ghai

Designation :

Director

Address :

Villa 6, Cluster 40, Jumeirah Islands, P. O. Box No. 18264, Dubai, 018264, United Arab Emirates

Date of Birth/Age :

30.08.1963

Qualification :

MBA

Date of Appointment :

10.08.2011

DIN No.:

00312672

 

 

Name :

Mr. Mahendra Swarup

Designation :

Alternate director

Address :

10.05.1953

Date of Birth/Age :

C-7, Paschimi Marg, Vasant Vihar, New Delhi – 110057, India

Qualification :

MBA

Date of Appointment :

08.05.2013

DIN No.:

01213634

 

 

Name :

Mr. Srinivas Chidambaram

Designation :

Director

Address :

S - 283, Ground Floor, Greater Kailash, Part - II, New Delhi – 110048, India

Date of Birth/Age :

21.05.1966

Qualification :

CA

Date of Appointment :

23.07.2012

DIN No.:

00514665

 

 

Name :

Brian William Tempest

Designation :

Director

Address :

South Park Farm, Grayswood Road, Haslemere, Surrey, GU272J, United Kingdom

Date of Birth/Age :

13.06.1947

Qualification :

Phd From Lancaster Univ

Date of Appointment :

04.02.2011

DIN No.:

00101235

 

 

Name :

Mr. Preetinder Singh Joshi

Designation :

Director

Address :

Maharaj Sawan Singh, Charitable Hospital, Beas -143201, Punjab, India

Date of Birth/Age :

17.11.1947

Qualification :

Master's Degree in Cardiology and General Medicine

Date of Appointment :

04.02.2011

DIN No.:

00109974

 

 

KEY EXECUTIVES

 

Name :

Mr. Ankush Agarwal

Designation :

Secretary

Address :

M – 7, Saket, New Delhi – 110017, India

Date of Birth/Age :

10.09.1978

Date of Appointment :

21.11.2007

PAN No.:

AKPPA0277J

 

 

Name :

Mr. Sanjeev Vashishta

Designation :

Chief Executive Officer

 

 

Name :

Dr. B. R. Das

Designation :

President - Research and Innovation

 

 

Name :

Mr. Kiran C. Vaidya

Designation :

Chief Operating Officer

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 20.09.2013

 

Names of Equity Shareholders

 

No. of Shares

 

Fortis Healthcare Limited, India

 

42749217

Avigo PE Investments Limited, Mauritius

 

6310315

Logos Holding Company Private Limited, India

 

4449772

Prime Trust, India

 

2000000

*IL& FS Trust Company Limited, India

 

1691542

Malav Holdings Private Limited, India

 

150000

Shivi Holdings Private Limited, India

 

150000

Spring Healthcare Private Limited, Mauritius

 

597015

Sabre Capital (Mauritius) Limited, Mauritius

 

199005

IL& FS Trust Company Limited (Dr. Avinash Achyut Phadke)

 

615000

IL& FS Trust Company Limited (Dr. Subhendu Roy)

 

615000

IL& FS Trust Company Limited (Dr. Bhavin Govindji Jankharia)

 

200000

IL& FS Trust Company Limited (Dr. Anita Maria Borges)

 

50000

IL& FS Trust Company Limited (Dr. Hemlata Madhav Purandare)

 

20000

 

 

 

Total

 

 

59796866

 

 

Names of Compulsorily Convertible Preference Shareholders

 

No. of Shares

 

International Finance Corporation, USA

 

4000000

NYLIM Jacob Ballas India Fund III LLC, Mauritius

 

8333333

 

 

 

Total

 

 

12333333

 

Note:

* Trustee of Spring Healthcare India Trust.

 

 

AS ON 20.09.2013

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

11.88

Bodies corporate

79.43

Others

8.69

 

 

Total

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the business of establishing, maintaining and managing clinical reference laboratories, to provide testing, diagnostics and prognostics monitoring/ screening tests on human beings and also provides laboratory support services for clinical research studies.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         HDFC Bank Limited

HDFC Bank House, Senapati Bapat Marg, Lower Parel [West], Mumbai - 400013, Maharashtra, India

 

·         Kotak Mahindra Bank Limited

15-16, UGF, Ambadeep Building, 14 K G Marg, New Delhi - 110001, Delhi, India

 

 

Facilities :

 

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Working capital loans from banks

33.891

432.840

Long-term maturities of finance lease

obligations

12.455

23.526

Other loans and advances

1475.427

73.541

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

134.191

218.884

 

 

 

Total

 

1655.964

748.791

 

 

 

Banking Relations :

--

 

 

Financial Institutions :

·         IDBI Trusteeship Services Limited

Asian Building, Ground Floor, 17, R. Kamani Marg, Ballard Estate, Mumbai - 400001, Maharashtra, India

 

·         GE Capital Services India

Aifcs Building, 1st Floor, 1, Rafi Marg, New Delhi - 110001, Delhi, India

 

 

Auditors :

 

Name :

S R Batliboi and Company LLP

Chartered Accountants

Address :

Golf View, Corporate Tower B, Sector-42, Sector Road, Gurgaon - 122002, Haryana, India

Income-tax PAN of auditor or auditor's firm :

ADTPC8611R

 

 

Holding company :

Fortis Healthcare Limited

 

 

Subsidiary company :

SRL Diagnostics Private Limited

 

 

Joint venture :

SRL Diagnostics (Nepal) Private Limited

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

·         Aegon Religare Life Insurance Company Limited [U66010MH2007PLC169110]

Bar Chem

Dion Global Solutions Limited [L74899DL1994PLC058032]

Escorts Heart Institute And Research Centre Limited [U85110CH2000PLC023744]

Escorts Heart And Super Speciality Hospital Limited [U85110DL2003PLC120016]

Escorts Heart And Super Speciality Institute Limited [U85110HR1998PLC048142]

Escorts Hospital And Research Centre Limited [U85110HR1997PLC048256]

Fortis C-Doc Healthcare Limited [U85110DL2010PLC208379]

Fortis Clinical Research Limited [U73100DL2005PLC134482]

Fortis Global Healthcare Limited [U74140DL2009PLC195148]

Fortis Health Management Limited [U85110DL2008PLC176412]

Fortis Hospital Management Limited [U85110DL2008PLC176522]

Fortis Hospitals Limited [U93000DL2009PLC222166]

Fortis Malar Hospitals Limited [L85110TN1989PLC017232]

Hiranandani Healthcare Private Limited [U85100MH2005PTC154823]

International Hospital Limited [U74999HR1994PLC048225]

Kanishka Healthcare Limited [U85100HR1988PLC048080]

Krishna Institute Of Medical Sciences Limited [U55101AP1973PLC040558]

Lalitha Healthcare Private Limited [U85110KA2005PTC035863]

REL Infrafacilities Limited [U45200DL2007PLC158928]

Religare Health Insurance Company Limited [U66000DL2007PLC161503]

RGAM Corporation Private Limited [U67120TN2004PTC053155]

Quality Healthcare Medical Services Ltd

Ligare Aviation Limited [U63040DL1996PLC166014]

Religare Capital Markets Limited [U51909DL2007PLC159042]

Religare Enterprises Limited [L74899DL1984PLC146935]

Religare Finvest Limited [U74999DL1995PLC064132]

Religare Securities Limited [U65910DL1986PTC151115]

HealthFore Technologies Limited [L72300DL2009PLC190552]

Ligare Travels Limited [U74899DL1989PLC036140]

Ligare Voyages Limited [U62100DL2006PLC149800]

RHC Holding Private Limited [U67190DL2007PTC162322]

Sunrise Medicare Private Limited [U74899DL1983PTC014923]

DDRC SRL Diagnostics Private Limited [U85190MH2006PTC161480]

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

61,333,334

Equity Shares

Rs. 10/- each

Rs. 613.333 Millions

10,000,000

Non-Cumulative Redeemable Preference Shares

Rs. 10/- each

Rs. 100.000 Millions

12,333,333

Compulsorily Convertible Preference Shares

Rs. 20/- each

Rs. 246.667 Millions

 

 

 

 

 

Total

 

Rs. 960.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

59,796,866

Equity Shares

Rs. 10/- each

Rs. 597.968 Millions

12,333,333

Compulsorily Convertible Preference Shares

Rs. 20/- each

Rs. 246.667 Millions

 

 

 

 

 

Total

 

Rs. 844.635 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

844.635

697.969

619.990

(b) Reserves & Surplus

6448.219

4006.996

2915.917

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

7292.854

4704.965

3535.907

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1521.773

2179.907

2522.409

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

16.029

40.123

11.745

(d) long-term provisions

31.281

22.578

12.606

Total Non-current Liabilities (3)

1569.083

2242.608

2546.760

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

134.191

252.684

882.071

(b) Trade payables

331.008

324.026

240.866

(c) Other current liabilities

787.038

803.515

506.908

(d) Short-term provisions

21.268

12.979

10.102

Total Current Liabilities (4)

1273.505

1393.204

1639.947

 

 

 

 

TOTAL

10135.442

8340.777

7722.614

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1203.312

973.931

792.310

(ii) Intangible Assets

34.325

30.732

21.051

(iii) Capital work-in-progress

2.453

285.350

353.700

(iv) Intangible assets under development

64.390

23.494

0.000

(b) Non-current Investments

3912.441

3912.441

3912.441

(c) Deferred tax assets (net)

64.187

0.000

0.000

(d)  Long-term Loan and Advances

3770.696

519.703

402.020

(e) Other Non-current assets

7.022

6.323

7.466

Total Non-Current Assets

9058.826

5751.974

5488.988

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

160.941

140.062

117.138

(c) Trade receivables

536.472

507.902

380.861

(d) Cash and cash equivalents

59.981

50.612

60.676

(e) Short-term loans and advances

317.674

1883.094

1618.893

(f) Other current assets

1.548

7.133

56.058

Total Current Assets

1076.616

2588.803

2233.626

 

 

 

 

TOTAL

10135.442

8340.777

7722.614

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Revenue from Operations

3618.314

2766.141

2242.543

 

 

Other Income

262.000

323.259

224.198

 

 

TOTAL                                     (A)

3880.314

3089.400

2466.741

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1198.877

948.103

855.271

 

 

Purchases of Stock-in-Trade

226.754

99.092

0.000

 

 

Employees benefits expense

835.318

675.595

531.137

 

 

Other expenses

1086.439

963.699

874.508

 

 

TOTAL                                     (B)

3347.388

2686.489

2260.916

 

 

 

 

 

Less

PROFIT/ [LOSS] BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

532.926

402.911

205.825

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

133.573

343.903

245.675

 

 

 

 

 

 

PROFIT/ [LOSS] BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

399.353

59.008

(39.850)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

253.567

192.972

150.546

 

 

 

 

 

 

PROFIT/ [LOSS] BEFORE TAX (E-F)                  (G)

145.786

(133.964)

(190.396)

 

 

 

 

 

Less

TAX                                                                  (H)

5.923

0.000

0.000

 

 

 

 

 

 

PROFIT/ [LOSS] AFTER TAX (G-H)                   (I)

139.863

(133.964)

(190.396)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Value of services rendered

23.600

29.722

72.537

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Capital Goods

32.402

20.744

22.114

 

 

Materials

0.294

0.841

2.016

 

TOTAL IMPORTS

32.696

21.585

24.130

 

 

 

 

 

 

Earnings/ [Loss] Per Share (Rs.)

 

 

 

 

Basic

2.34

(2.27)

(4.78)

 

Diluted

1.90

(2.27)

(4.78)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

3.60

(4.34)

(7.72)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

4.03

(4.84)

(8.49)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.39

(3.25)

(5.51)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.02

(0.03)

(0.05)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.23

0.52

0.96

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.85

1.86

1.36

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

619.990

697.969

844.635

Reserves & Surplus

2915.917

4006.996

6448.219

Net worth

3535.907

4704.965

7292.854

 

 

 

 

long-term borrowings

2522.409

2179.907

1521.773

Short term borrowings

882.071

252.684

134.191

Total borrowings

3404.480

2432.591

1655.964

Debt/Equity ratio

0.963

0.517

0.227

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2242.543

2766.141

3618.314

 

 

23.348

30.807

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2242.543

2766.141

3618.314

Profit/ [Loss]

(190.396)

(133.964)

139.863

 

(8.49%)

(4.84%)

3.87%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10414390

15/01/2014 *

1,500,000,000.00

IDBI TRUSTEESHIP SERVICES LIMITED

ASIAN BLDG., GROUND FLOOR, 17, R.KAMANI MARG, BALLARD ESTATE, MUMBAI, MAHARASHTRA - 400001, INDIA

B95535522

2

10325028

27/07/2012 *

120,000,000.00

KOTAK MAHINDRA BANK LIMITED

15-16 UPPER GROUND FLOOR, AMBADEEP BUILDING, 14, 
KASTURBA GANDHI MARG, NEW DELHI, DELHI - 110001, INDIA

B45177060

3

10320386

15/11/2011

58,681,500.00

HDFC BANK LIMITED

HDFC BANK HOUSE, SENAPATI BAPAT MARG, LOWER PAREL W, MUMBAI, MAHARASHTRA - 400013, INDIA

B26475558

4

10253040

19/10/2010

125,500,000.00

SREI EQUIPMENT FINANCE PRIVATE LIMITED

'VISHWAKARMA', 86C, TOPSIA ROAD, KOLKATA, WEST BENGAL - 700046, INDIA

A99899221

5

10115038

14/08/2013 *

340,000,000.00

HDFC BANK LIMITED

HDFC BANK HOUSE, SENAPATI BAPAT MARG, LOWER PAREL W, MUMBAI, MAHARASHTRA - 400013, INDIA

B84238344

 

* Date of charge modification

 

 

UNSECURED LOANS

 

UNSECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Debentures

0.000

1650.000

SHORT TERM BORROWINGS

 

 

Other loans and advances

0.000

33.800

 

 

 

Total

 

0.000

1683.800

 

 

CHANGE OF ADDRESS:

 

The Registered Office of the company has been shifted from 3rd Floor, 6 Devika Tower, Nehru Place, New Delhi – 110019, India to the present address w.e.f.01.01.2010.

 

 

GENERAL INFORMATION

 

SRL Limited (Formerly Super Religare Laboratories Limited) ("the Company") is a public company domiciled in India and incorporated under provisions of the Companies Act, 1956. The Company is in the business of establishing, maintaining and managing clinical reference laboratories, to provide testing, diagnostics and prognostics monitoring/ screening tests on human beings. The Company also provides laboratory support services for clinical research studies.

 

 

STANDALONE BASIS

 

During the financial year ended March 31, 2013; the Company has recorded total income of Rs 3880.310 Millions, which is 25.60 % higher than the previous financial year’s total income of Rs 3089.400 Millions. The Profit before Tax stood at Rs 145.790 Millions which is 208.83% higher as compared to the loss of Rs (133.960) Millions in the previous financial year. During the current financial year, Company has created Debenture Redemption Reserve of Rs 119.820 Millions as compared to the corresponding previous year’s reserve of Rs Nil. Deficit carried to the Balance Sheet for the fiscal year is Rs (531.790) Millions which is 3.63% lower as compared to the corresponding previous year’s deficit of Rs. (551.810) Millions. EBIDTA of the Company for the period under review is Rs. 532.930 Millions (i.e. after deducting prior period expenses of Rs. 1.007 Millions) which is 32.27% higher as compared to previous year’s EBIDTA of Rs. 402.910 Millions (i.e. after deducting prior period expenses of Rs. 2.270 Millions).

 

 

FUTURE OUTLOOK

 

The future outlook for the Company continues to be bright and encouraging. The Company has maintained its market leadership both in terms of geographic expansion and the expansion of the test menu, both in Lab Medicine and Radio Imaging. The continued modernization of healthcare services in India will ensure that the Company is successful in leveraging its geographic and scientific leadership by offering its services to patients, doctors and customers in all parts of India and in all overseas markets that Company serves. The Company is cognizant of the fact that consumer perception in diagnostics industry is as good as the experience of every single user of the services. To ensure that every patient and customer and every prescribing doctor is happy with the SRL experience, the Company continues to invest in training of employees and partners at all times. The Company has always been proud of its immensely talented and motivated pool of employees and this remains the source of greatest strength for ensuring continued growth and success in the future.

 

 

OPERATIONS

 

The Company is the leading diagnostic laboratory network in India, successfully delivering global Standard Diagnostic services, both in the field of Laboratory Medicine and Radio Imaging. As on June 30, 2013 the Company’s laboratory network extends to 241 Laboratories (which includes Owned Labs, Franchisee Labs, Fortis Labs, Other Hospital Labs, International Labs and Wellness Centers) and over 4000 Collection Points. The Company, being committed to quality, has highest number of accredited labs - 29 labs accredited by the NABL (ISO 15189:2007) and 4 labs accredited by CAP.

 

 

AWARD AND RECOGNITION

 

During the period, the Company was awarded ‘The Best Use of Technology by a Diagnostic Service provider’ for their CLIMS Cloud application at the e-India Health Summit 2012 under the "Innovative Use of Technology by a Diagnostic Service Provider" category.

 

The Company was also conferred with the FICCI 2012 special jury recognition award for Operational Excellence - Private Sector.

 

Further, for second consecutive year, SRL entered into LIMCA Book of for launching, e-Pathology, Food Intolerance Test for first time in India and for being the first lab in India to achieve NABL accreditation.

 

 

FIXED ASSETS:

 

·         Plant and equipment

Other plant and equipment

Furniture and fixtures

Vehicles

Motor vehicles

Office equipment

Computer equipments

Leasehold improvements

Computer equipments

Recipes, formulae, models, designs and prototypes


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.25

UK Pound

1

Rs. 103.02

Euro

1

Rs. 81.90

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

66

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.